Skip to content
healthcare.dev

Contrave Extended-Release

NDC 51267-890, naltrexone hydrochloride and bupropion hydrochloride, tablet, extended release, from Nalpropion Pharmaceuticals LLC.

Product NDC
51267-890
Status
Listed
Labeler
Nalpropion Pharmaceuticals LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA200063
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51267-890 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NALTREXONE HYDROCHLORIDE8 mg/1
  • BUPROPION HYDROCHLORIDE90 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]; Opioid Antagonist [EPC]; Opioid Antagonists [MoA]

Package NDCNDC-11Package
51267-890-07512670890077 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-07)
51267-890-9951267089099120 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-99)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/485ff360-32c8-11df-928b-0002a5d5c51b

Use it

Look up 51267-890 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51267-890 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51267-890. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.